Personalized Perioperative Treatment for NSCLC

Created using ChatSlide

This presentation explores comprehensive advancements in lung cancer management through personalized, biomarker-guided treatment frameworks. Emphasizing both preoperative and postoperative cancer care, it integrates clinical staging with molecular profiling, focusing on EGFR/ALK mutations, PD-L1 expression, and ctDNA-MRD. We provide insight into the evolving perioperative landscape, regulatory progress, and the benefits observed in driver-negative ICI trials. The session also discusses...